HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melengestrol acetate and megestrol acetate are prostatic tumor inhibiting agents.

Abstract
We had previously reported that 6-methylene progesterone, an inhibitor of 5 alpha-reductase, the enzyme which converts testosterone to dihydrotestosterone, markedly inhibited growth of the androgen-dependent Dunning R3327-H rat prostatic tumors. We now find that the progesterone derivatives melengestrol acetate (MGA) and megestrol acetate (MA) inhibit both the androgen-dependent (Dunning R3327-H) and the androgen-independent (Dunning R3327-AT3) prostatic tumors. Growth of the AT3 tumors was suppressed by approximately 53% after 9 days of daily s.c. injections with MGA at 10 mg/kg body weight. MGA also caused a 54% weight reduction of the ventral prostate and a 53% reduction of the seminal vesicles. Adrenal weights were reduced by 42%. A 24-day oral treatment with MGA (at approximately 15-17 mg/(kg.day)) inhibited AT3 tumor growth by 59% and caused a weight reduction in the following tissues: prostate (46%), seminal vesicles (19%), testes (12%), and adrenals (52%). Under the same protocol, MA inhibited AT3 tumor growth by 32% and reduced the weight of the ventral prostate by 49% and the weight of the adrenals by 18%, but had no effect on the seminal vesicles and testes. The extent of the MGA-induced prostatic regression was accompanied by cytological changes similar to those effected by 6-methylene progesterone, i.e., shrinking of the acinar epithelium. The AT3 tumors in MGA-treated rats displayed a limited degree of apoptosis. Atrophy of the adrenal cortex and lowered plasma levels of corticosterone and dihydroepiandrosterone were also observed. A therapeutic role for MGA and MA against androgen-independent prostatic neoplasms in man is forecast by these observations.
AuthorsG M Padilla, R C Yacullo, J J Padilla, B Payne, V Petrow
JournalBiochemistry and cell biology = Biochimie et biologie cellulaire (Biochem Cell Biol) Vol. 68 Issue 10 Pg. 1181-8 (Oct 1990) ISSN: 0829-8211 [Print] Canada
PMID2268413 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Melengestrol Acetate
  • Megestrol
  • Megestrol Acetate
Topics
  • Adrenal Glands (drug effects, pathology)
  • Animals
  • Antineoplastic Agents
  • Dose-Response Relationship, Drug
  • Male
  • Megestrol (analogs & derivatives, pharmacology)
  • Megestrol Acetate
  • Melengestrol Acetate (pharmacology)
  • Neoplasms, Hormone-Dependent (drug therapy, pathology)
  • Prostate (drug effects, pathology)
  • Prostatic Neoplasms (drug therapy, pathology)
  • Rats
  • Rats, Inbred Strains
  • Seminal Vesicles (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: